Clinical Trials Browser

OTHER × Leukemia, Prolymphocytic, T-Cell × INCB039110 × Clear all

NCT03989466 2024-10-10

Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Prolymphocytic, T-Cell